ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2028

Microwave and Magnetic (M2) Myocardial Proteomics in the Mouse Model of Kawasaki Disease Demonstrates Normalization of the Proteome after Interleukin-1 Inhibition, Potential Novel Biomarkers, and Suggests New Insights into Mechanism of Disease

Mark Gorelik1, Carol Chase2, Magali Noval Rivas3, Jean Patterson1, Moshe Arditi3 and Thomas Forsthuber2, 1Immunology and Virology, Texas Biomedical Research Institute, San Antonio, TX, 2University of Texas San Antonio, San Antonio, TX, 3Pediatrics, Cedars Sinai, Beverly Hills, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Kawasaki disease, mechanisms and proteomics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Kawasaki disease (KD), a predominantly coronary vasculitis of childhood, remains the most common cause of acquired heart disease of childhood in the developed world, and the developing concerns of myocardial damage in the form of cardiac fibrosis amplifies the urgency for a greater understanding both in terms of management and mechanism of this illness. At present, no biomarkers exist for the disease, response to therapy, persistence of inflammation or long term fibrosis; similarly, our understanding of the overall mechanism of the arterial remodeling and myocardial damage in KD is limited. Microwave and magnetic (M2) proteomics is a method whereby accelerated processing of proteins allows for high-throughput sample preparation and isolation of peptides for mass spectrometry. Our hypothesis was that protein biomarkers for vascular and myocardial inflammation would be identifiable in cardiac tissue from mice with a model of KD, that these markers would show response to a therapy such as interleukin-1 (IL-1) inhibition, offering insight into disease mechanisms.

Methods: KD was induced via the established model of lactobacillus casei cell wall extract (LCWE) injection in 4-6 week old male mice. Groups of mice either injected with LCWE alone, LCWE and anakinra, or saline for normal controls. After 2 weeks, mice were sacrificed and aortic root region of the heart was extracted, homogenized and processed. Tissue then underwent mass spectrometry analysis. Probability-based protein database searching of spectra was performed. Data was analyzed for pathway enrichment using STRING and REACTOME pathway analysis.

Results: Several proteins demonstrated multifold elevation in diseased animals as compared to controls, with certain proteins with primarily skeletal muscle and cardiac muscle expression notably elevated and down expressed after therapy. Proteomic analysis demonstrated clustering of diseased (KD) animals apart from controls and anakinra treated animals, which clustered together when analyzed by k-means testing. Preliminary pathway analysis suggests that in KD diseased hearts, there is enrichment for proteins involved in platelet aggregation and activation (p<0.01) and cardiac epithelial to mesenchymal transformation (p=0.04). Anakinra treated animals demonstrate enrichment for wnt signaling and downstream wnt signaling effectors beta-catenin and T cell factor (TCF) (p=0.01).

Conclusion: Potential biomarker proteins for disease activity and response to therapy were found based on the hypothesis of differential protein expression therapy and disease. These proteins require further validation. Overall, anakinra treated animals had a cardiac proteome that was more similar to normal controls than to KD mice. Preliminary pathway analysis suggested pathways for vascular injury and intimal hyperplasia in diseased animals, and induction of a regulatory immune phenotype mediated by wnt/beta-catenin in anakinra treated animals.


Disclosure: M. Gorelik, None; C. Chase, None; M. Noval Rivas, None; J. Patterson, None; M. Arditi, None; T. Forsthuber, None.

To cite this abstract in AMA style:

Gorelik M, Chase C, Noval Rivas M, Patterson J, Arditi M, Forsthuber T. Microwave and Magnetic (M2) Myocardial Proteomics in the Mouse Model of Kawasaki Disease Demonstrates Normalization of the Proteome after Interleukin-1 Inhibition, Potential Novel Biomarkers, and Suggests New Insights into Mechanism of Disease [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/microwave-and-magnetic-m2-myocardial-proteomics-in-the-mouse-model-of-kawasaki-disease-demonstrates-normalization-of-the-proteome-after-interleukin-1-inhibition-potential-novel-biomarkers-and-sugg/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microwave-and-magnetic-m2-myocardial-proteomics-in-the-mouse-model-of-kawasaki-disease-demonstrates-normalization-of-the-proteome-after-interleukin-1-inhibition-potential-novel-biomarkers-and-sugg/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology